Below are six genetic databases and their drug industry partners:
1. 23andMe — which has genetic data from about 5 million individuals — partners with Genentech and GlaxoSmithKline.
2. deCODE Genetics — which has data from about 1.6 million people — partners with Amgen.
3. UK Biobank — which has data from 500,000 people — partners with AbbVie, Alnylam, AstraZeneca, Biogen, Bristol-Myers Squibb, GlaxoSmithKline, Pfizer, Regeneron and Takeda.
4. Geisinger — which supplies data from 250,000 people — partners with Regeneron.
5. Mayo Clinic — which supplies data from 100,000 people — partners with Regeneron.
6. FinnGen — which has data from about 147,000 people — partners with AbbVie, AstraZeneca, Biogen, Celgene, Genentech, GlaxoSmithKline, Merck & Co., Pfizer and Sanofi.
More articles on pharmacy:
Oklahoma opioid trial wraps: 10 takeaways
Drugmaker tried to shred records before FDA inspection, agency claims
Publix Pharmacy to deliver prescriptions to patients before hospital discharge
